Flavio Arienti

4.8k citations

58 papers · 1.8k indexed · h-index 26

Impact in

Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers

Papers in

Immunology 42
- Immunotherapy and Immune Responses 35
- Immune Cell Function and Interaction 16
- T-cell and B-cell Immunology 12
Oncology 29
- CAR-T cell therapy research 20
- Cancer Immunotherapy and Biomarkers 7

Co-authors: Giorgio Parmiani Licia Rivoltini Cecilia Melani Mario P. Colombo Filiberto Belli S Ferrone Carlo Gambacorti‐Passerini Josep Sulé-Suso
Journals: Human Gene Therapy (5 papers)Blood (5 papers)Cancer Immunology Immunotherapy (4 papers)The Journal of Immunology (3 papers)Clinical Cancer Research (2 papers)
Partner nations: Italy United States United Kingdom

In The Last Decade

Flavio Arienti

57 papers receiving 1.7k citations

Peers

Countries citing papers authored by Flavio Arienti

Since Specialization

Citations

This map shows the geographic impact of Flavio Arienti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Flavio Arienti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Flavio Arienti more than expected).

Fields of papers citing papers by Flavio Arienti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Flavio Arienti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Flavio Arienti. The network helps show where Flavio Arienti may publish in the future.

Co-authors

The 25 scholars most cited alongside Flavio Arienti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Flavio Arienti Line = papers co-authored together Flavio Arienti links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Identification of the novel HLA‐C allele, HLA‐C04:520* HLA ·M Zucchini, Camilla Billiani, Arabella Mazzocchi, Flavio Arienti, Francesca Taverna	2024	1
2	Monocytes in leukapheresis products affect the outcome of CD19–targeted CAR T-cell therapy in patients with lymphoma Blood Advances ·Cristiana Carniti, Nicole Caldarelli, Luca Agnelli, T. Torelli, Silva Ljevar, Sadhana Jonnalagadda, Giada Zanirato, Eugenio Fardella, Federico Stella, Daniele Lorenzini, Silvia Brich, Flavio Arienti, Anna Dodero, Annalisa Chiappella, Martina Magni, Paolo Corradini	2024	7
3	Shear-Induced Encapsulation into Red Blood Cells: A New Microfluidic Approach to Drug Delivery Annals of Biomedical Engineering ·Monica Piergiovanni, Giustina Casagrande, Francesca Taverna, Ilaria Corridori, M. Frigerio, Elena Bianchi, Flavio Arienti, Arabella Mazzocchi, Gabriele Dubini, Maria Laura Costantino	2019	16
4	Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib Treatment Journal of Investigative Dermatology ·Marcella Tazzari, Valentina Indio, Barbara Vergani, Loris De Cecco, Francesca Rini, Tiziana Negri, Chiara Camisaschi, Marco Fiore, Silvia Stacchiotti, Gian Paolo Dagrada, Paolo G. Casali, Alessandro Gronchi, Annalisa Astolfi, Maria A. Pantaleo, Antonello Villa, Claudia Lombardo, Flavio Arienti, Silvana Pilotti, Licia Rivoltini, Chiara Castelli	2016	29
5	Epidural analgesia for cytoreductive surgery with peritonectomy and heated intraperitoneal chemotherapy International Journal of Surgery ·Federico Piccioni, Claudia Casiraghi, Luca Fumagalli, Shigeki Kusamura, Dario Baratti, Marcello Deraco, Flavio Arienti, Martin Langer	2015	16
6	Predictors of CD34+ Cell Mobilization and Collection in Adult Men With Germ Cell Tumors: Implications for the Salvage Treatment Strategy Clinical Genitourinary Cancer ·Andrea Necchi, Rosalba Miceli, Paolo Pedrazzoli, Patrizia Giannatempo, Simona Secondino, Massimo Di Nicola, Elena Farè, Daniele Raggi, Michele Magni, Paola Matteucci, Paolo Longoni, Marco Milanesi, Emanuela Paternò, Fernando Ravagnani, Flavio Arienti, Nicola Nicolai, Roberto Salvioni, Carmelo Carlo‐Stella, Alessandro M. Gianni	2013	3
7	Tumor-Reactive CD8+ Early Effector T Cells Identified at Tumor Site in Primary and Metastatic Melanoma Cancer Research ·Andrea Anichini, Alessandra Molla, Claudia Vegetti, Ilaria Bersani, Roberta Zappasodi, Flavio Arienti, Fernando Ravagnani, Andrea Maurichi, Roberto Patuzzo, Mario Santinami, Hanspeter Pircher, Massimo Di Nicola, Roberta Mortarini	2010	38
8	Impaired STAT Phosphorylation in T Cells from Melanoma Patients in Response to IL-2: Association with Clinical Stage Clinical Cancer Research ·Roberta Mortarini, Claudia Vegetti, Alessandra Molla, Flavio Arienti, Fernando Ravagnani, Andrea Maurichi, Roberto Patuzzo, Mario Santinami, Andrea Anichini	2009	23
9	Induction of Both CD8+ and CD4+ T-Cell–Mediated Responses in Colorectal Cancer Patients by Colon Antigen-1 Clinical Cancer Research ·Cristina Maccalli, Veronica Di Cristanziano, Valentina Fodale, Domenico Corsi, Giuseppina D’Agostino, Valentina Petrangeli, Luca Laurenti, Sofia Guida, Arabella Mazzocchi, Flavio Arienti, Maria Paola Perrone, Chiara Castelli, Licia Rivoltini, Vittorina Zagonel, Marco Tartaglia, Giorgio Parmiani, Filippo Belardelli	2008	8
10	Detection of mutated BRAFV600E variant in circulating DNA of stage III–IV melanoma patients International Journal of Cancer ·Maria Daniotti, Viviana Vallacchi, Licia Rivoltini, Roberto Patuzzo, Mario Santinami, Flavio Arienti, Gianluca Cutolo, Marco A. Pierotti, Giorgio Parmiani, Monica Rodolfo	2007	57
11	Soluble Human LAG-3 Molecule Amplifies the In vitro Generation of Type 1 Tumor-Specific Immunity Cancer Research ·Chiara Casati, Chiara Camisaschi, Francesca Rini, Flavio Arienti, Licia Rivoltini, Frédéric Triebel, Giorgio Parmiani, Chiara Castelli	2006	60
12	Role of Cross-Talk between IFN-α-Induced Monocyte-Derived Dendritic Cells and NK Cells in Priming CD8+ T Cell Responses against Human Tumor Antigens The Journal of Immunology ·Diégo Tosi, Roberta Valenti, Agata Cova, Gloria Sovena, Veronica Huber, Lorenzo Pilla, Flavio Arienti, Filippo Belardelli, Giorgio Parmiani, Licia Rivoltini	2004	78
13	Induction and functional characterization of β 2-microglobulin (β2-μ)-free HLA class I heavy chains expressed by β2-μ-deficient human FO-1 melanoma cells European Journal of Immunology ·Zhigang Wang, Flavio Arienti, Giorgio Parmiani, S Ferrone	1998	11
14	Recognition of Melanoma-Derived Antigens by CTL: Possible Mechanisms Involved in Down-Regulating Anti-Tumor T-Cell Reactivity Critical Reviews in Immunology ·Licia Rivoltini, Douglas J. Loftus, Paola Squarcina, Chiara Castelli, Francesca Rini, Flavio Arienti, Filiberto Belli, Francesco M. Marincola, Carsten Geisler, Alessandro Borsatti, Ettore Appella, Giorgio Parmiani	1998	26
15	Cytokine Gene Transduction in the Immunotherapy of Cancer Advances in pharmacology ·Giorgio Parmiani, Mario P. Colombo, Cecilia Melani, Flavio Arienti	1997	38
16	A Human Melanoma Cell Line Transduced with an Interleukin-4 Gene by a Retroviral Vector Releases Biologically Active IL-4 and Maintains the Original Tumor Antigenic Phenotype Human Gene Therapy ·Cecilia Melani, Josep Sulé-Suso, Flavio Arienti, Cristina Maccalli, F Passerini, Mario P. Colombo, Giorgio Parmiani	1995	9
17	A B7‐1‐transfected human melanoma line stimulates proliferation and cytotoxicity of autologous and allogeneic lymphocytes European Journal of Immunology ·Josep Sulé-Suso, Flavio Arienti, Cecilia Melani, Mario P. Colombo, Giorgio Parmiani	1995	41
18	Treatment of recurrent in transit metastases from cutaneous melanoma by isolation perfusion in extracorporeal circulation with interleukin-2 and lymphokine activated killer cells. A pilot study Melanoma Research ·Filiberto Belli, Flavio Arienti, Licia Rivoltini, Mario Santinami, L. Mascheroni, A. Prada, Mario Ammatuna, Edoardo Marchesi, Giorgio Parmiani, N. Cascinelli, Maurizio Vaglini	1992	6
19	Phenotypic and functional analysis of lymphocytes infiltrating paediatric tumours, with a characterization of the tumour phenotype Cancer Immunology Immunotherapy ·Licia Rivoltini, Flavio Arienti, Attilio Orazi, Graziella Cefalo, Marco Gasparini, Carlo Gambacorti‐Passerini, Franca Fossati‐Bellani, Giorgio Parmiani	1992	37
20	The high lysability by lak cells of colon‐carcinoma cells resistant to doxorubicin is associated with a high expression of ICAM‐1, LFA‐3, NCA and a less‐differentiated phenotype International Journal of Cancer ·Licia Rivoltini, Giorgio Cattoretti, Flavio Arienti, Antonio Mastroianni, Cecilia Melani, Mario P. Colombo, Giorgio Parmiani	1991	42

About Flavio Arienti

Flavio Arienti is a scholar working on Immunology, Oncology, Biological Psychiatry, Immunology and Allergy and Hematology, having authored 58 papers that have together received 1.8k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (35 papers), CAR-T cell therapy research (20 papers), Immune Cell Function and Interaction (16 papers), T-cell and B-cell Immunology (12 papers), Cancer Immunotherapy and Biomarkers (7 papers), Virus-based gene therapy research (6 papers), vaccines and immunoinformatics approaches (6 papers) and Viral Infectious Diseases and Gene Expression in Insects (5 papers). The work is most often cited by research in Immunology (1.2k citations), Oncology (900 citations), Hematology (120 citations), Radiology, Nuclear Medicine and Imaging (186 citations) and Biological Psychiatry (20 citations). Flavio Arienti has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Giorgio Parmiani, Licia Rivoltini, Cecilia Melani, Mario P. Colombo, Filiberto Belli, S Ferrone, Carlo Gambacorti‐Passerini, Josep Sulé-Suso, Chiara Castelli and Daniel J. Hicklin. Their work appears in journals such as Human Gene Therapy, Blood, Cancer Immunology Immunotherapy, The Journal of Immunology and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact